These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Incidental findings on 18-FDG PET-CT in head and neck cancer. A retrospective case-control study of incidental findings on 18-FDG PET-CT in patients with head and neck cancer. Casselden E; Sheerin F; Winter SC Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):243-247. PubMed ID: 30535976 [TBL] [Abstract][Full Text] [Related]
24. Distant metastases and synchronous malignancies on FDG-PET/CT in patients with head and neck cancer: a retrospective study. Flygare L; Al-Ubaedi A; Öhman W; Mo SJ Acta Radiol; 2020 Sep; 61(9):1196-1204. PubMed ID: 31902218 [TBL] [Abstract][Full Text] [Related]
25. Is there any additional benefit of contrast-enhanced CT as part of routine PET/CT protocols for the differentiation of suspicious incidental gastrointestinal 2-deoxy-(18)F-FDG uptake? Brendle CB; Aschoff P; Kratt T; Schraml C; Reimold M; Claussen CD; Pfannenberg CA Korean J Radiol; 2013; 14(6):951-9. PubMed ID: 24265572 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic Value of Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037 [TBL] [Abstract][Full Text] [Related]
27. Clinical significance of Zhang Y; Han J; Li J; Cao J; Zhou Y; Deng S; Zhang B; Yang Y J Cancer Res Clin Oncol; 2024 May; 150(5):265. PubMed ID: 38769201 [TBL] [Abstract][Full Text] [Related]
28. Staging Voskuilen CS; van Gennep EJ; Einerhand SMH; Vegt E; Donswijk ML; Bruining A; van der Poel HG; Horenblas S; Hendricksen K; van Rhijn BWG; Mertens LS Eur Urol Oncol; 2022 Jun; 5(3):366-369. PubMed ID: 33583752 [TBL] [Abstract][Full Text] [Related]
29. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer. Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086 [TBL] [Abstract][Full Text] [Related]
30. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma. Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135 [TBL] [Abstract][Full Text] [Related]
31. Bosma SE; Vriens D; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Bloem JL Skeletal Radiol; 2019 Nov; 48(11):1735-1746. PubMed ID: 31016339 [TBL] [Abstract][Full Text] [Related]
32. Second cancers discovered by (18)FDG PET/CT imaging for choroidal melanoma. Chin K; Finger PT; Kurli M; Tena LB; Reddy S Optometry; 2007 Aug; 78(8):396-401. PubMed ID: 17662928 [TBL] [Abstract][Full Text] [Related]
34. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study. Caobelli F; Alongi P; Evangelista L; Picchio M; Saladini G; Rensi M; Geatti O; Castello A; Laghai I; Popescu CE; Dolci C; Crivellaro C; Seghezzi S; Kirienko M; De Biasi V; Cocciolillo F; Quartuccio N; Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775 [TBL] [Abstract][Full Text] [Related]
35. Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer. van Westreenen HL; Westerterp M; Jager PL; van Dullemen HM; Sloof GW; Comans EF; van Lanschot JJ; Wiggers T; Plukker JT J Nucl Med; 2005 Aug; 46(8):1321-5. PubMed ID: 16085589 [TBL] [Abstract][Full Text] [Related]
36. Low positive yield from routine inclusion of the brain in whole-body 18F-FDG PET/CT imaging for noncerebral malignancies: results from a large population study. Manohar K; Bhattacharya A; Mittal BR Nucl Med Commun; 2013 Jun; 34(6):540-3. PubMed ID: 23503001 [TBL] [Abstract][Full Text] [Related]
38. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315 [TBL] [Abstract][Full Text] [Related]
39. Incidence of Brain Metastases on Follow-up Nia ES; Garland LL; Eshghi N; Nia BB; Avery RJ; Kuo PH J Nucl Med Technol; 2017 Sep; 45(3):193-197. PubMed ID: 28705927 [TBL] [Abstract][Full Text] [Related]
40. Discordant results in Parisse-Di Martino S; Faure C; Mognetti T Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]